血清sTREM-1联合降钙素原对老年胆道结石术后继发急性胆管炎的预测价值

doi:10.3969/j.issn.1003-9198.2024.07.016

摘要/Abstract

摘要： 目的探讨联合检测血清可溶性髓系细胞触发受体-1(sTREM-1)和降钙素原(PCT)对老年胆道结石术后继发急性胆管炎(AC)的预测价值。方法以2019年1月至2022年9月收治的145例行胆道结石术的老年病人作为研究对象,按术后是否继发AC将病人分为对照组(未继发AC,n=56)和观察组(继发AC,n=89),再根据AC病情程度将观察组病人分为轻度(n=37)、中度(n=29)和重度(n=23)3个亚组。检测各组病人血清WBC、CRP、PCT和sTREM-1水平并进行比较。采用Logistic回归分析继发AC以及AC严重程度的影响因素;绘制ROC曲线分析PCT和sTREM-1水平对老年胆道结石术后继发AC的预测效能。结果与对照组比较,观察组血清WBC、CRP、PCT和sTREM-1水平显著升高(P＜0.01)。与轻度组比较,中度组和重度组病人血清CRP、PCT和sTREM-1水平均显著升高;与中度组比较,重度组病人血清WBC和PCT水平显著升高(均P＜0.05)。Logistic回归分析结果显示,血清CRP、PCT和sTREM-1水平升高是老年胆道结石术后继发AC和AC重症的独立危险因素(均P＜0.05)。ROC曲线评估结果显示,血清PCT和sTREM-1联合检测对术后继发AC以及AC严重程度的预测效能均显著高于单一指标(均P＜0.05)。结论胆道结石术后继发AC的老年病人血清PCT和sTREM-1水平明显升高,二者联合检测对胆道结石术后继发AC具有预测价值。

关键词: 可溶性髓系细胞触发受体-1, 降钙素原, 老年人, 胆道结石, 急性胆管炎, 预测价值

Abstract: Objective To investigate the predictive value of serum soluble myeloid cell trigger receptor-1 (sTREM-1) and procalcitonin (PCT) for secondary acute cholangitis (AC) in the elderly patients undergoing biliary calculi surgery. Methods A total of 145 elderly patients undergoing biliary calculus surgery from January 2019 to September 2022 were enrolled in this study, and the patients were divided into control group (without postoperative AC, n=56) and observation group (with postoperative AC, n=89). According to the degree of AC, the observation group was divided into three subgroups: mild group (n=37), moderate group (n=29) and severe group (n=23). The serum levels of white blood cells (WBC), C-reactive protein (CRP), PCT and sTREM-1 were detected and compared among the groups. Logistic regression was used to analyze the influencing factors of secondary AC and the severity. ROC curve was drawn to analyze the predictive efficiency of PCT and sTREM-1 levels for secondary AC in the elderly patients undergoing biliary caculi surgery. Results Compared with control group, the serum levels of WBC, CRP, PCT and sTREM-1 in observation group were significantly increased (P<0.01). Compared with mild group, the serum CRP, PCT and sTREM-1 levels in moderate group and severe group were significantly increased; Compared with moderate group, the serum levels of WBC and PCT in severe group were significantly increased (all P<0.05).Logistic regression analysis showed that the serum levels of CRP, PCT and sTREM-1 were the independent risk factors of postoperative AC and severe degree in the elderly patients (all P<0.05). ROC curve results showed that the combination detection of serum PCT and sTREM-1 showed higher predicting efficiency than single detection of them in predicting the incidence of postoperative AC and the severe degree (all P<0.05). Conclusions The serum PCT and sTREM-1 levels in the elderly patients with secondary AC after biliary calculi operation are significantly increased, and the combined detection of PCT and sTREM-1 has good predictive value for the incidence of postoperative AC.

Key words: soluble myeloid cell trigger receptor-1, procalcitonin, aged, biliary stones, acute cholangitis severity, predictive value

中图分类号:

R 657.4

石毅, 高骥, 王鹏, 芮一奇, 白剑峰. 血清sTREM-1联合降钙素原对老年胆道结石术后继发急性胆管炎的预测价值[J]. 实用老年医学, 2024, 38(7): 713-717.

SHI Yi, GAO Ji, WANG Peng, RUI Yiqi, BAI Jianfeng. Value of serum sTREM-1 combined with procalcitonin in predicting secondary acute cholangitis in elderly patients after biliary calculisurgery[J]. Practical Geriatrics, 2024, 38(7): 713-717.

参考文献

[1] AGUIAR R G P, SOUZA JÚNIOR F E A, ROCHA JÚNIOR J L G, et al. Clinical and epidemiological evaluation of complications associated with gallstones in a tertiary hospital[J]. Arq Gastroenterol, 2022, 59(3): 352-357.
[2] DING Y, MEN W. A case report and review of acute cholangitis with septic shock induced by Edwardsiella tarda[J]. Ann Clin Microbiol Antimicrob, 2022, 21(1): 33.
[3] 刘少博, 杜宇璠, 孙雪莲, 等. 血小板减少是急性胆管炎的危险信号[J]. 临床和实验医学杂志, 2022, 21(2): 138-141.
[4] KIRIYAMA S, KOZAKA K, TAKADA T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1): 17-30.
[5] YOKOE M, HATA J, TAKADA T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1): 41-54.
[6] INAN O, SAHINER E S, ATES I. Factors associated with clinical outcome in geriatric acute cholangitis patients[J]. Eur Rev Med Pharmacol Sci, 2023, 27(8): 3313-3321.
[7] BELIAEV A M, BARTLETT A, BERGIN C. Diagnostic inflammatory markers of acute cholangitis in liver transplant recipients[J]. ANZ J Surg, 2021, 91(3): 439-444.
[8] JIANG J, WANG X, CHENG T, et al. Dynamic monitoring of strem-1 and other biomarkers in acute cholangitis[J]. Mediators Inflamm, 2020, 2020: 8203813.
[9] UMEFUNE G, KOGURE H, HAMADA T, et al. Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study[J]. J Gastroenterol, 2017, 52(6): 734-745.
[10] MIURA F, OKAMOTO K, TAKADA T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1): 31-40.
[11] LE BOT A, SOKAL A, CHOQUET A, et al. Clinical and microbiological characteristics of reflux cholangitis following bilio-enteric anastomosis[J]. Eur J Clin Microbiol Infect Dis, 2022, 41(8): 1139-1143.
[12] LI Y L, WONG K H, CHIU K W, et al. Percutaneous cholecystostomy for high-risk patients with acute cholangitis[J]. Medicine: Baltimore, 2018, 97(19): e0735.
[13] KOGURE H, TSUJINO T, YAMAMOTO K, et al. Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage[J]. J Gastroenterol, 2011, 46(12): 1411-1417.
[14] WACKER C, PRKNO A, BRUNKHORST F M, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2013, 13(5): 426-435.
[15] KYRIAZOPOULOU E, LIASKOU-ANTONIOU L, ADAMIS G, et al. Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial[J]. Am J Respir Crit Care Med, 2021, 203(2): 202-210.
[16] LI Y, MIN L, ZHANG X. Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children[J]. BMC Pulm Med, 2021, 21(1): 386.
[17] GIBOT S, KOLOPP-SARDA M N, BÉNÉ M C, et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis[J]. J Exp Med, 2004, 200(11): 1419-1426.
[18] FANG C, MAO Y, JIANG M, et al. Serum sTREM-1 and CXCL-16 levels in children with Mycoplasma pneumoniae pneumonia and their diagnostic value[J]. Evid Based Complement Alternat Med, 2021, 2021: 7179796.
[19] DOUGHTY C, O'DRISCOLL D N, SMITH S, et al. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in neonatal sepsis[J]. Matern Fetal Neonatal Med, 2022, 35(13): 2485-2492.
[20] DONG C, YUAN H, XU R, et al. Efficacy of infection control pathway in reducing postoperative infections in patients undergoing neurosurgery[J]. J Infect Dev Ctries, 2020, 14(1): 74-79.
[21] KAYSER S, BRUNNER P, ALTHAUS K, et al. Selective apheresis of c-reactive protein for treatment of indications with elevated CRP concentrations[J]. J Clin Med, 2020, 9(9): 2947.